US stocks open higher, Moderna jumps 90%

The headline confirms a sharp 90% surge in Moderna's stock, indicating that strong momentum may continue in the short term. However, the RSI at 94.8 is in overbought territory, posing a risk that could temper the rally's pace. The MACD remains positive and above its signal line, suggesting the trend is still upward. While the price trading well above the SMA20 and SMA50 points to short-term overheating, the combination of news flow and a favorable market environment increases the likelihood that the uptrend may persist for a while longer. Nevertheless, rather than initiating new positions at these levels, it may be more prudent to hold existing positions or consider profit-taking.

The positive sentiment at the broader market open may provide short-term support for GOOGL shares. However, the stock has lost 1.2% over the last 24 hours, and with an RSI of 37, it remains in a weak zone, indicating sustained selling pressure. The MACD is in negative territory but is approaching its signal line, suggesting a slight improvement in momentum. Trading below both the SMA20 and SMA50 keeps the technical outlook weak. Therefore, any upside expectations should be cautious, as a strong recovery would require breaking through resistance levels.

The news headline points to a positive market opening, which could support risk appetite. However, technical indicators are mixed: RSI is in the weak zone at 42.6, MACD is negative, and the price is below both the SMA20 and SMA50. In the short term, the bullish opening may trigger some buying on dips, but since the trend is still downward, this move is likely to be limited. Overall, some recovery can be expected due to the news, but caution is advised as no strong signal has been formed.

NDX has dropped 1.97% in the last 24 hours, with its RSI at 32.9, approaching oversold territory. The MACD is in negative territory but remains below the signal line, indicating weak short-term momentum. The price is below both the SMA20 and SMA50, confirming a downward overall trend. However, the bullish opening in the news headline and Moderna's surge may signal a short-term recovery in risk appetite. Therefore, the direction is uncertain, but a slight upward reaction is possible due to oversold conditions and positive news flow.